skip to main content
Idioma:
Refinado por: assunto: Science & Technology remover Nome da Publicação: Hepatology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C
A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C
Material Type:
Artigo 		Adicionar ao Meu Espaço

A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C

Dienstag, Jules L. ; Ghany, Marc G. ; Morgan, Timothy R. ; Di Bisceglie, Adrian M. ; Bonkovsky, Herbert L. ; Kim, Hae‐Young ; Seeff, Leonard B. ; Szabo, Gyongyi ; Wright, Elizabeth C. ; Sterling, Richard K. ; Everson, Gregory T. ; Lindsay, Karen L. ; Lee, William M. ; Lok, Anna S. ; Morishima, Chihiro ; Stoddard, Anne M. ; Everhart, James E.

Hepatology (Baltimore, Md.), 2011-08, Vol.54 (2), p.396-405 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
2
Excess mortality in patients with advanced chronic hepatitis C treated with long‐term peginterferon
Excess mortality in patients with advanced chronic hepatitis C treated with long‐term peginterferon
Material Type:
Artigo 		Adicionar ao Meu Espaço

Excess mortality in patients with advanced chronic hepatitis C treated with long‐term peginterferon

Di Bisceglie, Adrian M. ; Stoddard, Anne M. ; Dienstag, Jules L. ; Shiffman, Mitchell L. ; Seeff, Leonard B. ; Bonkovsky, Herbert L. ; Morishima, Chihiro ; Wright, Elizabeth C. ; Snow, Kristin K. ; Lee, William M. ; Fontana, Robert J. ; Morgan, Timothy R. ; Ghany, Marc G.

Hepatology (Baltimore, Md.), 2011-04, Vol.53 (4), p.1100-1108 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
3
Racial differences in hepatitis C treatment eligibility
Racial differences in hepatitis C treatment eligibility
Material Type:
Artigo 		Adicionar ao Meu Espaço

Racial differences in hepatitis C treatment eligibility

Melia, Michael T. ; Muir, Andrew J. ; McCone, Jonathan ; Shiffman, Mitchell L. ; King, John W. ; Herrine, Steven K. ; Galler, Greg W. ; Bloomer, Joseph R. ; Nunes, Frederick A. ; Brown, Kimberly A. ; Mullen, Kevin D. ; Ravendhran, Natarajan ; Ghalib, Reem H. ; Boparai, Navdeep ; Jiang, Ruiyun ; Noviello, Stephanie ; Brass, Clifford A. ; Albrecht, Janice K. ; McHutchison, John G. ; Sulkowski, Mark S.

Hepatology (Baltimore, Md.), 2011-07, Vol.54 (1), p.70-78 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
4
Occult and previous hepatitis B virus infection are not associated with hepatocellular carcinoma in United States patients with chronic hepatitis C
Occult and previous hepatitis B virus infection are not associated with hepatocellular carcinoma in United States patients with chronic hepatitis C
Material Type:
Artigo 		Adicionar ao Meu Espaço

Occult and previous hepatitis B virus infection are not associated with hepatocellular carcinoma in United States patients with chronic hepatitis C

Lok, Anna S. ; Everhart, James E. ; Di Bisceglie, Adrian M. ; Kim, Hae‐Young ; Hussain, Munira ; Morgan, Timothy R.

Hepatology (Baltimore, Md.), 2011-08, Vol.54 (2), p.434-442 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
5
Variants in interferon‐alpha pathway genes and response to pegylated interferon‐Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long‐term treatment against cirrhosis trial
Variants in interferon‐alpha pathway genes and response to pegylated interferon‐Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long‐term treatment against cirrhosis trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Variants in interferon‐alpha pathway genes and response to pegylated interferon‐Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long‐term treatment against cirrhosis trial

Welzel, Tania Mara ; Morgan, Timothy R. ; Bonkovsky, Herbert L. ; Naishadham, Deepa ; Pfeiffer, Ruth M. ; Wright, Elizabeth C. ; Hutchinson, Amy A. ; Crenshaw, Andrew T. ; Bashirova, Arman ; Carrington, Mary ; Dotrang, Myhanh ; Sterling, Richard K. ; Lindsay, Karen L. ; Fontana, Robert J. ; Lee, William M. ; Di Bisceglie, Adrian M. ; Ghany, Marc G. ; Gretch, David R. ; Chanock, Stephen J. ; Chung, Raymond T. ; O'Brien, Thomas R.

Hepatology (Baltimore, Md.), 2009-06, Vol.49 (6), p.1847-1858 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
6
Predicting clinical outcomes using baseline and follow‐up laboratory data from the hepatitis C long‐term treatment against cirrhosis trial
Predicting clinical outcomes using baseline and follow‐up laboratory data from the hepatitis C long‐term treatment against cirrhosis trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Predicting clinical outcomes using baseline and follow‐up laboratory data from the hepatitis C long‐term treatment against cirrhosis trial

Ghany, Marc G. ; Kim, Hae‐Young ; Stoddard, Anne ; Wright, Elizabeth C. ; Seeff, Leonard B. ; Lok, Anna S.F.

Hepatology (Baltimore, Md.), 2011-11, Vol.54 (5), p.1527-1537 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.